During the recent session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 1.35 million, with the beta value of the company hitting -1.37. At the last check today, the stock’s price was $22.01, reflecting an intraday gain of 18.77% or $3.48. The 52-week high for the GPCR share is $62.74, that puts it down -185.05 from that peak though still a striking 39.94% gain since the share price plummeted to a 52-week low of $13.22. The company’s market capitalization is $1.26B, and the average intraday trading volume over the past 10 days was 0.96 million shares, and the average trade volume was 846.97K shares over the past three months.
Structure Therapeutics Inc ADR (GPCR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. GPCR has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.23.
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Structure Therapeutics Inc ADR (GPCR) registered a 18.77% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 18.77% in intraday trading to $22.01, hitting a weekly high. The stock’s 5-day price performance is 46.23%, and it has moved by -2.49% in 30 days. Based on these gigs, the overall price performance for the year is -41.81%. The short interest in Structure Therapeutics Inc ADR (NASDAQ:GPCR) is 6.91 million shares and it means that shorts have 8.56 day(s) to cover.
The consensus price target of analysts on Wall Street is $93, which implies an increase of 76.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $65 and $118 respectively. As a result, GPCR is trading at a discount of -436.12% off the target high and -195.32% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -51.75%. While earnings are projected to return 6.55% in 2025, the next five years will return -25.24% per annum.
GPCR Dividends
Structure Therapeutics Inc ADR is due to release its next quarterly earnings on 2025-Feb-26. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
Structure Therapeutics Inc ADR insiders own 6.01% of total outstanding shares while institutional holders control 110.23%, with the float percentage being 117.28%. WELLINGTON MANAGEMENT GROUP LLP is the largest shareholder of the company, while 235.0 institutions own stock in it. As of 2024-06-30, the company held over 7.55 million shares (or 1.7124% of all shares), a total value of $296.41 million in shares.
The next largest institutional holding, with 5.74 million shares, is of FMR LLC’s that is approximately 1.3033% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $225.6 million.
Also, the Mutual Funds coming in first place with the largest holdings of Structure Therapeutics Inc ADR (GPCR) shares are SMALLCAP WORLD FUND INC and VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund . Data provided on Dec 31, 2024 indicates that SMALLCAP WORLD FUND INC owns about 4.44 shares. This amounts to just over 7.74 percent of the company’s overall shares, with a $94.63 million market value. The same data shows that the other fund manager holds slightly less at 4.25, or about 7.41% of the stock, which is worth about $90.63 million.
